Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
2016; Elsevier BV; Volume: 127; Issue: 11 Linguagem: Inglês
10.1182/blood-2015-10-672071
ISSN1528-0020
AutoresMarco Mielcarek, Terry Furlong, Paul V. O’Donnell, Barry E. Storer, Jeannine S. McCune, Rainer Storb, Paul A. Carpenter, Mary E.D. Flowers, Frederick R. Appelbaum, Paul J. Martin,
Tópico(s)Polyomavirus and related diseases
ResumoKey Points With conventional immunosuppression, the incidence of chronic GVHD is higher after transplantation of mobilized blood compared with marrow. Administration of cyclophosphamide after mobilized blood cell transplantation is associated with a low incidence of chronic GVHD.
Referência(s)